<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kimiko</forename><surname>Ohgi</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Odontology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Hiroshi</forename><surname>Kajiya</surname></persName>
							<email>kajiya@college.fdcnet.ac.jp</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Science and Molecular Biology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Physiological Science and Molecular Biology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kazuko</forename><surname>Goto-T</surname></persName>
							<idno type="ORCID">0000-0003-3275-3632</idno>
							<affiliation key="aff3">
								<orgName type="department">Department of Dental Hygiene</orgName>
								<orgName type="institution">Fukuoka College of Health Sciences</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fujio</forename><surname>Okamoto</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Science and Molecular Biology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Physiological Science and Molecular Biology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yasunori</forename><surname>Yoshinaga</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Odontology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Koji</forename><surname>Okabe</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Science and Molecular Biology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Physiological Science and Molecular Biology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ryuji</forename><surname>Sakagami</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Odontology</orgName>
								<orgName type="institution">Fukuoka Dental College</orgName>
								<address>
									<postCode>8140193</postCode>
									<settlement>Fukuoka</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">D545C68BC8E50B709759828834C67472</idno>
					<idno type="DOI">10.1186/s12944-018-0787-4</idno>
					<note type="submission">Received: 28 January 2018 Accepted: 23 May 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Dyslipidemia</term>
					<term>Osteoclastogenesis</term>
					<term>Toll-like receptor</term>
					<term>Lectin-like oxidized low-density-lipoprotein receptor 1</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Lectin-like oxidized low-density-lipoprotein receptor 1 (Lox-1) is the receptor for oxidized low-density lipoprotein (oxLDL), a mediator in dyslipidemia.</s><s>Toll-like receptor (TLR)-2 and âˆ’ 4 are receptors of lipopolysaccharide (LPS) from Porphyromonas gingivalis, a major pathogen of chronic periodontitis.</s><s>Although some reports have demonstrated that periodontitis has an adverse effect on dyslipidemia, little is clear that the mechanism is explained the effects of dyslipidemia on osteoclastogenesis.</s><s>We have hypothesized that osteoclast oxLDL has directly effect on osteoclasts (OCs), and therefore alveolar bone loss on periodontitis may be increased by dyslipidemia.</s><s>The present study aimed to elucidate the effect of Lox-1 on osteoclastogenesis associated with TLRs in vitro.</s></p><p><s>Methods: Mouse bone marrow cells (BMCs) were stimulated with macrophage colony-stimulating factor into bone marrow macrophages (BMMs).</s><s>The cells were also stimulated with synthetic ligands for TLR2 (Pam3CSK4) or TLR4 (Lipid A), with or without receptor activator of nuclear factor kappa-B ligand (RANKL), and assessed for osteoclastogenesis by tartrate-resistant acid phosphatase (TRAP) staining, immunostaining, western blotting, flow activated cell sorting (FACS) analysis, real-time polymerase chain reaction (PCR), and reverse transcription PCR.</s></p><p><s>Results: Lox-1 expression was significantly upregulated by Pam3CSK4 and Lipid A in BMCs (p &lt; 0.05), but not in BMMs.</s><s>FACS analysis identified that Pam3CSK4 upregulated RANK and Lox-1 expression in BMCs.</s><s>TRAP-positive cells were not increased by stimulation with Pam3CSK4 alone, but were increased by stimulation with combination combined Pam3CSK and oxLDL.</s><s>Expression of both Lox-1 and myeloid differentiation factor 88 (MyD88), an essential adaptor protein in the TLR signaling pathway, were suppressed by inhibitors of TLR2, TLR4 and mitogen-activated protein kinase (MAPK).</s></p><p><s>Conclusions: This study supports that osteoclastogenesis is promoted under the coexistence of oxLDL by TLR2-induced upregulation of Lox-1 in BMCs.</s><s>This indicates that periodontitis could worsen with progression of dyslipidemia.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Osteoclasts (OCs) are multinucleated, bone-adhering cells, formed by fusion of mononuclear monocyte/macrophage progenitors.</s><s>OCs require macrophage colony-stimulating factor (M-CSF) for proliferation and receptor activator of nuclear factor kappa-B ligand (RANKL) for fusion and maturation <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref>.</s><s>OCs act by extruding acid onto the bone surface and dissolving inorganic components within the bone matrix <ref type="bibr" target="#b4">[5]</ref>.</s><s>Periodontitis is a chronic disease caused by bacterial infection in the gingiva <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>, resulting in resorption of alveolar bone.</s><s>It is reported that lipopolysaccharide (LPS), a major constituent of Gram-negative bacteria, can stimulate OC formation and bone resorption through activation of Toll-like receptors (TLRs) <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s>Porphyromonas gingivalis (P.</s><s>gingivalis) is an anaerobic Gram-negative oral bacterium involved in periodontitis.</s><s>LPS derived from P. gingivalis is different to that derived from other bacteria and acts as an agonist of both TLR4 and TLR2 <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>P. gingivalis aggravates periodontal bone resorption through differential regulation of TLR2 and TLR4 signaling pathways in a RANKL-dependent manner <ref type="bibr" target="#b12">[13]</ref>.</s><s>Although TLR ligands have been shown to have stimulatory or inhibitory functions on osteoclastogenesis in vitro, TLR4 ligand has been shown to be a potent stimulator of bone loss in vivo <ref type="bibr" target="#b13">[14]</ref>.</s><s>It has been reported that P. gingivalis LPS stimulates periosteal OC formation due to induction of RANKL in osteoblasts by activation of TLR2 <ref type="bibr" target="#b14">[15]</ref>.</s><s>Of note, alveolar bone loss is induced by P. gingivalis through TLR2 in mice <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>Conversely, synthetic TLR2 ligand inhibits OC formation in mouse bone marrow macrophages (BMMs) stimulated with macrophage colony-stimulating factor (M-CSF) and RANKL <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s>Although RANKL induces differentiation of BMMs to OCs, simultaneous addition of LPS inhibits this process <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>However, LPS stimulation at late-stage osteoclastogenesis enhances the survival and activation of OCs <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>.</s><s>Although P. gingivalis has known to promote osteoclastogenesis and bone resorption which types of TLR receptor, such as TLR2 and/or TLR4 promote bone resorption remains unclear.</s></p><p><s>Lectin-like oxidized low-density lipoprotein receptor-1 (Lox-1) was discovered as a receptor for oxidized low-density lipoprotein (oxLDL) in endothelium and vascular-rich organs <ref type="bibr" target="#b22">[23]</ref>.</s><s>Lox-1 is a multi-ligand receptor that recognizes many ligands, such as activated platelets <ref type="bibr" target="#b23">[24]</ref>, neutrophils <ref type="bibr" target="#b24">[25]</ref>, apoptotic/aged cells <ref type="bibr" target="#b25">[26]</ref>, and bacteria <ref type="bibr" target="#b26">[27]</ref>, and is expressed in many cell types <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref>.</s><s>Bone-resorbing OCs and bone-forming osteoblasts have been reported to express Lox-1, and Lox-1 âˆ’/âˆ’ mice have decreased bone mass in the steady state but are resistant to inflammatory bone destruction because of the impairment of osteoblastic RANKL expression in response to inflammation <ref type="bibr" target="#b30">[31]</ref>.</s></p><p><s>The pathology of both periodontitis and dyslipidemia involves OCs, and these lifestyle-related diseases are exacerbated by stimulation with TLRs and Lox-1, respectively.</s><s>Consequently, although these disorders are reported to be associated with each other, the mechanism for this is unclear <ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref>.</s><s>Some reports have shown that periodontitis increases the risk of atherosclerosis in vivo and in vitro <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>, and that periodontitis worsens in the apolipoprotein E (ApoE)âˆ’/âˆ’ hyperlipidemia model <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b38">39]</ref>.</s><s>However, there are few reports describing how dyslipidemia exacerbates periodontitis.</s></p><p><s>The purpose of this study was to clarify whether osteoclastogenesis is upregulated through Lox-1 by TLR stimulation at early-and late-stage.</s><s>We showed that osteoclastogenesis was accelerated by activation of TLRs through upregulation of Lox-1 expression during bone marrow cell (BMC) differentiation into BMMs, suggesting dyslipidemia increases the risk of periodontitis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>All procedures were approved by the Council on Animal Care of Fukuoka Dental College (13013).</s><s>Mouse BMCs were obtained from the tibia and femora of 4-to 5-week-old ddY male mice.</s><s>All mice were euthanized by cervical dislocation under anesthesia by inhalation of isoflurane at 0.5-5% with oxygen.</s><s>BMCs were cultured in Î±-Minimum Essential Medium (Î±-MEM; Invitrogen, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; Biowest Nuaille, France) and antibiotics (100 U/ml penicillin G and 0.15 mg/ml streptomycin sulfate).</s><s>After overnight culture to differentiate BMMs, non-adherent cells were cultured for 3 days with or without Pam3CSK4 (50-100 ng/ml) or lipid A (100 ng/ml) in the presence of macrophage colony-stimulating factor (M-CSF; 20 ng/ml).</s><s>For the control, phosphate-buffered saline (PBS) was administered instead of the TLR ligands.</s><s>In some experiments, BMMs were used as osteoclast precursors and further cultured with RANKL (50 ng/ml) in the presence or absence of TLR ligands for 3 days.</s><s>To identify OCs, cells were fixed with 3.7% formaldehyde and stained with tartrate-resistant acid phosphatase (TRAP) using the Acid Phosphatase Leukocyte Kit (Sigma-Aldrich, St. Louis, MO, USA), and defined as TRAP-positive multinucleated cells (having more than three nuclei).</s><s>OCs were counted using a microscope.</s><s>Each condition was tested in triplicate and all experiments were repeated at least three times.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reverse transcription (RT)-polymerase chain reaction (PCR) and real-time PCR</head><p><s>Total RNA was extracted from cells using TRIzol reagent (Life Technologies Corporation, Rockville, MD, USA).</s><s>First strand cDNA was synthesized using 1 mg total RNA with Super Script II RT according to the manufacturer's instructions (Invitrogen, Grand Island, NY, USA).</s><s>To detect mRNA expression of Lox-1 and Î²-actin, RT-PCR was performed using the following: Lox-1 sense 5â€²-AGACTGGCT CTGGCATAAAG-3â€², antisense 5â€²-AAGGCCAACATGCT TTACAT-3â€²; Î²-actin sense 5â€²-TGAGAGGGAAATCG TGCGT-3â€², antisense 5â€²-GCTGGAAGGTGGACAGTGA G-3â€².</s><s>PCR was performed under the following conditions: 1 min denaturation at 95 Â°C, 1 min annealing at 55 Â°C, and 1 min extension at 72 Â°C, using 36 cycles.</s><s>PCR products were subjected to electrophoresis on 2% agarose gel and visualized with ethidium bromide.</s><s>To examine the effects of MAPK inhibitors on Lox-1 mRNA expression, BMCs in the presence of M-CSF (20 ng/ml) were cultured with or without Pam3CSK4 (100 ng/ml) or Lipid A (100 ng/ml) for 3 days after incubation with TLR2/4 inhibitor (25 Î¼M) or MAPK inhibitors, SP600125 (5 Î¼M) as c-Jun N-terminal kinase (JNK) inhibitor or U0126 (10 Î¼M) as MAP/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor, respectively, for 1 h.</s><s>Signals of Lox-1 mRNA were normalized to Î²-actin mRNA expression levels using Image J software (NIH, Bethesda, MD, USA).</s></p><p><s>To quantify mRNA levels, cDNA samples were analyzed by quantitative real-time PCR.</s><s>A total of 1 mg of cDNA was amplified in a 20 Î¼l volume of Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) in a real-time PCR system (Bio-rad CFX96, Bio-rad Technologies, Inc., Santa Clara, CA, USA) and the fluorescence was monitored at each cycle.</s><s>Cycle parameters were 95 Â°C for 30 s to activate Taq followed by 40 cycles of 95 Â°C for 5 s, 60 Â°C for 10 s, and 72 Â°C for 40 s.</s><s>For real-time analysis, two standard curves were constructed from amplicons for both the Î²-actin and target gene.</s><s>Target gene cDNA units in each sample were normalized to Î²-actin cDNA units.</s><s>Finally, the relative target gene expression units were expressed as arbitrary units, calculated according to the following formula: relative target gene expression units = target gene cDNA units/Î²-actin cDNA units.</s><s>To detect mRNA expression of Lox-1, MyD88 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), real-time PCR was performed using the following sets: Lox-1 sense 5â€²-CTGCGAATGACGAGCCTGA-3â€², antisense 5â€²-TCACTGACAACACCAGGCAGAG-3â€²; MyD88 sense 5â€²-TACAGGTGGCCAGAGTGGAA-3â€², antisense 5â€²-GCAGTAGCAGATAAAGGCATCGAA-3â€²; GAPDH sense 5â€²-TGTGTCCGTCGTGGATCTGA-3â€², antisense 5â€²-TTGCTGTTGAAGTCGCAGGAGâ€².</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunocytochemistry</head><p><s>Cells were fixed in 4% formaldehyde for 5 min and permeabilized with 0.05% Triton-Ã— 100 in phosphate-buffered saline (PBS) for 5 min.</s><s>Cells were incubated with goat polyclonal anti-rabbit Lox-1 antibody (1:100 dilution, ab60178, Abcam) overnight at 4 Â°C after blockade of nonspecific binding with 3% goat serum for 40 min at room temperature.</s><s>Cells treated with primary antibody were washed with PBS and incubated with Alexa fluor 488-conjugated streptavidin (2 Î¼g/ml, Molecular Probes, Eugene, OR) in goat anti-rabbit IgG secondary antibody (1:1500 dilution, Vector Laboratories, Burlingame, CA) for 30 min at room temperature.</s><s>To label cell nuclei, cells were rinsed in PBS and covered with encapsulant containing 4â€²,6-diamidino-2-phenylindole (DAPI).</s><s>Fluorescence was observed using fluorescence microscopy (TMD 300, Nikon).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FACS analysis</head><p><s>BMCs were cultured for 3 days in Î±-MEM containing 10% FBS and M-CSF with or without Pam3CSK4 (100 ng/ml) or Lipid A (100 ng/ml) for 3 days.</s><s>Cells were washed twice with PBS and incubated with anti-Lox-1 and anti-RANK antibodies conjugated with phycoerythrin.</s><s>The labeled cells were analyzed on a FACS using On Chip (On Chip Bio.</s><s>Tec., Tokyo, Japan).</s><s>The ratio of Lox-1-or RANK-positive cells among the total non-adherent BMCs was quantified using the labeled square.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blot analysis</head><p><s>Cells were lysed in Tris-NaCl-Tween (TNT) buffer containing 20 mM tris-HCl (pH 7.5), 200 mM NaCl, 1% Triton X-100, 1 mM dithiothreitol (DTT), and protease inhibitors (Roche, Basel, Switzerland).</s><s>The protein content of the samples was measured using Pierce reagents, following the manufacturer's protocol.</s><s>Protein samples (20 Î¼g) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and proteins were then transferred to a polyvinylidene difluoride (PVDF) membrane (100 V, 1 h, 4 Â°C).</s><s>The membranes were incubated with anti-FDPS and anti-Î²-actin antibodies diluted at 1:1000 in 5% (w/v) skimmed milk solution supplemented with 0.01% (w/v) azide overnight at 4 Â°C.</s><s>The blots were washed in Tris-buffered saline with Tween (TTBS) (10 mM tris-HCl, 50 mM NaCl, 0.25% Tween 20) and incubated with an appropriate secondary antibody for 30 min at room temperature.</s><s>The immunoreactive proteins were visualized using enhanced chemiluminescence reagents (GE Healthcare, Tokyo, Japan).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chemicals</head><p><s>Recombinant human RANKL and M-CSF were purchased from Peprotec Co. Ltd. (Minneapolis, MN, USA).</s><s>All other chemicals were obtained from Sigma-Aldrich.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data analysis</head><p><s>All data are expressed as mean Â± standard error of the mean (SEM) of the number of cells (n).</s><s>Statistical comparisons were performed using analysis of variance (ANOVA).</s><s>A probability (P) of &lt; 0.05 was considered significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression of Lox-1 was upregulated by TLR 2/4 ligands in BMCs</head><p><s>To clarify the effect of TLR ligands on the expression of Lox-1 in BMCs or BMMs, cells were cultured with or without Pam3CSK4 (100 ng/ml) or Lipid A (100 ng/ml) in the presence of M-CSF for 3 days (Fig. <ref type="figure" target="#fig_0">1a</ref>).</s><s>Exposure to Pam3CSK4 or Lipid A significantly upregulated the expression of Lox-1 in BMCs (p &lt; 0.05) (upper panel) but suppressed Lox-1 expression in BMMs (lower panel) compared with the control.</s><s>Lox-1 mRNA expression in BMCs peaked on days 1 or 3 after incubation with Pam3CSK4 or Lipid A as assessed by real-time PCR (p &lt; 0.05) (Fig. <ref type="figure" target="#fig_0">1b</ref>, left panel).</s><s>Furthermore, Lox-1 protein expression peaked on day 3 after treatment with both TLR ligands (Fig. <ref type="figure" target="#fig_0">1b</ref>, right panel).</s><s>Similar to the PCR results, protein expression of Lox-1 was also upregulated following exposure to Pam3CSK4 or Lipid A in BMCs as assessed by immunocytochemistry (Fig. <ref type="figure" target="#fig_0">1c</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TLR2/4 ligands upregulate Lox-1 and RANK in BMCs</head><p><s>BMC surface expression of Lox-1 and RANK proteins was analyzed by FACS.</s><s>Treatment with M-CSF slightly increased the cell surface expression of Lox-1 in BMCs in a time-dependent manner compared with untreated cells (day 0; Fig. <ref type="figure">2</ref>, upper panel).</s><s>The addition of Pam3CSK4 or Lipid A significantly upregulated the expression of Lox-1 compared with the control cells (incubated with IgG).</s><s>Similar to the real-time PCR time course results, Lox-1 expression peaked at day 1 or day 3 after stimulation with Pam3CSK4 or Lipid A, respectively.</s><s>In the present experiments, RANKL induced the expression of RANK, and the addition of Pam3CSK4 or Lipid A upregulated the expression of RANK in BMCs in a time-dependent manner.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TLR 2/4 ligands upregulate the expression of Lox-1 in BMCs through activation of MAPK</head><p><s>To assess TLR2 or 4 activation of Lox-1 expression via the downstream pathways of TLR2/4, MyD88, and MAPKs, we examined the effects of these inhibitors on the expression of Lox-1 and RANK in BMCs using real-time PCR.</s><s>Although the addition of Pam3CSK4 or Lipid A significantly increased the expression of Lox-1 and MyD88 mRNAs, TLR2 or 4 ligand-induced upregulation was reduced in the presence of TLR2/4 and MAPK inhibitor peptides, respectively (Fig. <ref type="figure">3a</ref>), suggesting an influence towards Lox-1 expression by activation of TLR-MyD88 downstream signaling.</s><s>Furthermore, the inhibitors of JNK and MEK significantly inhibited the upregulation of TLR2-induced RANK mRNAs on BMCs (Fig. <ref type="figure">3b</ref>).</s><s>These results demonstrated that TLR2/4 ligands activated Lox-1 expression through the MEK and JNK activation pathway, including MyD88.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TLRs stimulation with oxLDL accelerates osteoclastogenesis at early-phase</head><p><s>To clarify TLR2-induced Lox-1 upregulation on osteoclastogenesis, we examined the effect of oxLDL (30 Î¼g/ml) on osteoclast differentiation on early-phase (BMC: day 0-3 before stimulation with RANKL) and/or on late-phase (BMM: day 0-3 after RANKL stimulation) osteoclastogenesis.</s><s>The number of TRAP-positive multinucleated cells were increased at early phase and decreased at late phase, b c Furthermore, Pam3CSK4 (10 ng/ml) had no effect on early-phase, but an inhibition effect at late-phase osteoclastogenesis (Fig. <ref type="figure" target="#fig_2">4a and b</ref> each middle panels).</s><s>When we stimulated BMCs with both Pam3CSK4 (25 ng/ml) and oxLDL (15 Î¼g/ml) at early-phase, numbers of TRAP-positive multinucleated cells were significantly increased (Fig. <ref type="figure" target="#fig_2">4a and b</ref> each lower panels).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>P. gingivalis is known to stimulate TLR2 and/or TLR4 <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref> via MyD88 to modulate osteoclastogenesis <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref>, resulting in alveolar bone resorption through differential regulation of TLR2 and TLR4 signaling pathways in a RANKL-dependent manner <ref type="bibr" target="#b12">[13]</ref>.</s><s>Although Lipid A, a TLR4 ligand, has been shown to be a potent stimulator of bone loss in vivo <ref type="bibr" target="#b13">[14]</ref>, little is known about whether other TLR ligands have a stimulatory or inhibitory effect on osteoclastogenesis in vitro.</s><s>Furthermore, many clinical studies show that osteoporosis is associated with atherosclerosis <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b43">44]</ref>.</s><s>Although atherosclerosis is reported to result in inhibited bone formation because oxLDL blocked differentiation of osteoblast progenitor cells <ref type="bibr" target="#b44">[45,</ref><ref type="bibr" target="#b45">46]</ref>, little is known about how dyslipidemia influences bone resorption.</s><s>In the present study, we found that TLRs upregulated the oxLDL receptor, Lox-1, via MAPK in BMCs, resulting in promotion of osteoclastogenesis.</s><s>This finding suggests that periodontitis would worsen with progression of dyslipidemia.</s></p><p><s>The subcutaneous or intraperitoneal administration of Pam3CSK4 is reported to upregulate bone resorption in vivo, suggesting that Pam3CSK4 directly promotes osteoclastogenesis from BMMs after RANKL priming <ref type="bibr" target="#b40">[41,</ref><ref type="bibr" target="#b46">47]</ref>.</s><s>However, synthetic TLR2 ligand inhibits OC formation in BMMs treated with M-CSF and RANKL in vitro <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref> Furthermore, combination of RANKL and LPS inhibited osteoclastogenesis <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>Our data also showed that numbers of TRAP-positive cells were decreased when BMMs were stimulated with Pam3CSK, compared with those treated with M-CSF and RANKL.</s><s>In contrast, the Fig. <ref type="figure">2</ref> BMC surface expression of Lox-1 and RANK proteins.</s><s>BMCs were cultured with or without Pam3CSK4 (TLR2 ligand, 100 ng/ml) or Lipid A (TLR4 ligand, 100 ng/ml) in the presence of M-CSF (20 ng/ml) for 3 days.</s><s>Cells were washed with PBS and incubated with anti-Lox-1 or anti-RANK antibodies.</s><s>Data are expressed as the mean Â± SEM (n = 3 experiments) addition of Pam3CSK and oxLDL, a Lox-1 ligand together at early phase, increased the number of TRAP-positive cells.</s><s>Although the mechanism through which P. gingivalis-induces bone resorption via TLR2 and TLR4 is not fully understood, our results suggest that TLR-stimulation in periodontitis upregulates alveolar bone resorption under high plasma concentration of oxLDL in dyslipidemia.</s></p><p><s>OC progenitors, including BMCs and BMMs, are reported to express abundant levels of LDL receptors, such as Lox-1, in a RANKL-independent manner.</s><s>Expression levels of Lox-1 are greatly decreased during osteoclastogenesis, particularly during the fusion of mononuclear cells to form multinuclear OCs <ref type="bibr" target="#b47">[48]</ref>.</s><s>The present data showed that Lox-1 expression was upregulated by TLR 2 or 4 ligands in BMCs but not in BMMs.</s><s>Periodontal tissues in ApoE âˆ’/âˆ’ hyperlipidemia model rats are reported to exhibit more TRAP-positive multinuclear cells and increased TLR2 and TLR4 expression levels <ref type="bibr" target="#b32">[33]</ref>, suggesting that high oxLDL concentration effects osteoclastogenesis via the elevation of TLRs.</s><s>OxLDL is reported to suppress RANKL-induced osteoclastogenesis, TRAP activity, and bone-resorbing activity derived from human peripheral blood mononuclear cells in vitro.</s><s>This suppression is suggested to be caused by RANKL-induced phosphorylation of ERK, p38, and JNK kinases, together with the suppression of DNA binding activities of transcriptional factors, such as nuclear factor-kappa B (NF-kappa-B) and nuclear fsctor of activated T-cells (NFAT) <ref type="bibr" target="#b48">[49]</ref>.</s><s>Our data demonstrated that TLR 2 or 4 ligand-induced Lox-1 upregulation was reduced in the presence of TLR2/4 and MAPK inhibitor, respectively, and the inhibitors of JNK and MEK significantly inhibited the upregulation of TLR 2-induced RANK mRNA on BMCs.</s><s>We also found that TLR-stimulation together with oxLDL accelerated early-phase but not late-phase osteoclastogenesis, and only oxLDL stimulation suppressed RANKL-induced osteoclastogenesis, consistent with previous studies.</s><s>In the present study, Pam3CSK4 was shown to upregulate the expression of RANK and Lox-1 in BMCs.</s><s>Furthermore, stimulation with both Pam3CSK4 and oxLDL was shown to promote progression of osteoclastogenesis, suggesting that oxLDL-Lox-1 signaling promotes osteoclastogenesis through expression of Lox-1 by stimulating TLRs.</s></p><p><s>Similar reports have shown that plasma lipids likely play a role in maintaining bone mass <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b49">50]</ref>.</s><s>A better understanding of the coupling between osteoporosis and atherosclerosis is indicated in previous studies whereby treatment of one disease may have beneficial effects on another <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s>The American Heart Association reported in 2012 that although periodontal interventions result in a reduction in systemic inflammation and endothelial dysfunction in short-term studies, there is no evidence that they prevent atherosclerotic cardiovascular disease (ASVD) or modify its outcomes <ref type="bibr" target="#b56">[57]</ref>.</s><s>Although our data could not support that ASVD developed due to periodontitis worsening dyslipidemia, it did show that osteoclastogenesis was upregulated by TLR-stimulation, like bacterial infection, in periodontitis with dyslipidemia.</s></p><p><s>In this study, we focused on elucidating the correlation between dyslipidemia and progression of periodontitis.</s><s>Our results indicated that stimulation of BMCs with TLRs, representative of a bacterial infection, upregulated Lox-1 expression resulting in promotion of osteoclastogenesis in the presence of oxLDL in dyslipidemia.</s><s>Although the present data did not clarify the direct relationships between periodontitis and atherosclerotic vascular disease, periodontitis at least partially worsens by the complication of dyslipidemia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>In conclusion, the activation of TLR 2 and/or 4 upregulated the expression of Lox-1 through activation of MAPK in BMCs but not in osteoblasts, suggesting the promotion of osteoclastogenesis during dyslipidemia.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Analysis of LOX-1 in bone marrow cells (BMCs) and bone marrow macrophages (BMMs).</s><s>(A, upper panel, B, C) BMCs were differentiated into BMMs with or without Pam3CSK4 (TLR2 ligand, 100 ng/ml) or Lipid A (TLR4 ligand, 100 ng/ml) in the presence of macrophage colony-stimulating factor (M-CSF, 20 ng/ml) for 3 days.</s><s>(A, lower panel) BMMs were cultured with or without Pam3CSK4 (100 ng/ml) or Lipid A (100 ng/ml) in the presence of M-CSF and receptor activator of nuclear factor kappa-B ligand (RANKL, 50 ng/ml) for 3 days.</s><s>a Polymerase chain reaction (PCR) products of LOX-1, a receptor of oxidative low density lipoprotein (oxLDL), mRNA in BMCs (upper panel) and BMMs (lower panel) were amplified using RT-PCR methods.</s><s>Following stimulation with Pam3CSK4 or Lipid A, Lox-1 expression was upregulated in BMCs (upper panel) but not in BMMs (lower panel).</s><s>b Lox-1 mRNA expression peaked on day 1 or 3 as determined by real-time PCR (left panel) and protein expression on day 3 (right panel).</s><s>c BMCs stimulated with TLR ligands on day 3 were stained with anti-Lox-1 antibody (1:100 dilution) then incubated with Alexa fluor 488-conjugated streptavidin (2 Î¼g/ml) in goat anti-rabbit IgG secondary antibody (1:1500 dilution).</s><s>Lox-1 expression was upregulated.</s><s>Data are expressed as mean Â± SEM (n = 3).</s><s>*P &lt; 0.05 compared with control</s></p></div></figDesc><graphic coords="4,165.43,96.56,301.96,258.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>3 Fig. 3</head><label>33</label><figDesc><div><p><s>Fig.3Real time PCR to determine Lox-1, MyD88 and RANK expression in BMCs following addition of inhibitors.</s><s>BMCs in the presence of M-CSF (20 ng/ml) were cultured with or without Pam3CSK4 (TLR2 ligand, 100 ng/ml) or Lipid A (TLR4 ligand, 100 ng/ml) for 3 days after incubation with TLR2/4 inhibitor (25 Î¼M) or MAPK inhibitors, SP600125 (5 Î¼M) as JNK inhibitor or U0126 (10 Î¼M) as MEK inhibitor, respectively, for 1 h.</s><s>a Both TLR2/4 inhibitor and MAPK inhibitors significantly suppressed TLR 2 or 4 ligand-induced upregulation of Lox-1 (upper panel) and MyD88 (lower panel) mRNA.</s><s>b SP600125 significantly suppressed TLR 2, but not TLR 4 ligand-induced upregulation of RANK mRNA, and U0126 upregulated RANK mRNA.</s><s>Data are expressed as the mean Â± SEM (n = 3 experiments)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>AbbreviationsFig. 4</head><label>4</label><figDesc><div><p><s>AbbreviationsApoE: Apolipoprotein E; ASVD: Atherosclerotic cardiovascular disease; BMC: Bone marrow cell; BMM: Bone marrow macrophage; ERK: Extracellular signal-regulated kinase; FACS: Fluorescence activated cell sorting; JNK: c-Jun N-terminal kinase; Lox-1: Lectin-like oxidized low-density-lipoprotein receptor 1; LPS: Lipopolysaccharide; MAPK: Mitogen-activated protein kinase; M-CSF: Macrophage colony-stimulating factor; MEK: MAPK/ERK kinase; MyD88: Myeloid differentiation factor 88; NFAT: Nuclear factor of activated T-cells; NF-kappa-b: Nuclear factor-kappa B; OC: Osteoclast; oxLDL: oxidized low-density lipoprotein; P. gingivalis: Porphyromonas gingivalis; PCR: Polymerase chain reaction; RANKL: Receptor activator of nuclear factor kappa-B ligand; TLR: Toll-like receptor; TRAP: Tartrate-resistant acid phosphatase</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="5,64.15,104.27,467.08,338.05" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Elizabeth Finnie, PhD, from Edanz Group (http://www.edanzediting.com/ac) for editing a draft of this manuscript.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This work was supported by a Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 15 K11405) and Private University Research Branding Project.</s><s>The authors report no conflicts of interest related to this study.</s><s>Ethics approval and consent to participate Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's Note</head><p><s>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Bone remodeling in rheumatic disease: a question of balance</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Gravallese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">233</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="301" to="312" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mechanisms and control of pathologic bone loss in periodontitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bartold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Cantley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Haynes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Periodontol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="55" to="69" />
			<date type="published" when="2000">2000. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment</title>
		<author>
			<persName><forename type="first">G</forename><surname>Schett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gravallese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Rheumatol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="656" to="664" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The role of cytokines in inflammatory bone loss</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">H</forename><surname>Lerner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Investig</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="555" to="622" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Osteoimmunology: interactions of the bone and immune system</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lorenzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Horowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="403" to="440" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mechanisms of alveolar bone destruction in periodontitis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goultschin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Dean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Boyan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Periodontol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="158" to="172" />
			<date type="published" when="1997">2000. 1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kajiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Giro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Taubman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Mayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kawai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Oral Microbiol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="16" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Lipopolysaccharide promotes the survival of osteoclasts via toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages</title>
		<author>
			<persName><forename type="first">K</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Udagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Okahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nishihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3688" to="3695" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha</title>
		<author>
			<persName><forename type="first">N</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ninomiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Udagawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="601" to="611" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Lack of toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukusaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Shiraishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kishimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kaneko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oral Microbiol Immunol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="190" to="195" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Transcriptional regulation of bone sialoprotein gene by Porphyromonas gingivalis lipopolysaccharide</title>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mezawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kaneko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ogata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="823" to="833" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Porphyromonas gingivalis lipopolysaccharide contains multiple lipid a species that functionally interact with both toll-like receptors 2 and 4</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Darveau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lemley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Reife</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Bainbridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Coats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Howald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Way</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Hajjar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="5041" to="5051" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of toll-like receptor 2 (TLR2) and TLR4</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kawai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Taubman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Han</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4127" to="4134" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sakuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yasoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ozasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Narumiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sugimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ichikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ushikubi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="6819" to="6825" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Porphyromonas gingivalis stimulates bone resorption by enhancing RANKL (receptor activator of NF-ÎºB ligand) through activation of toll-like receptor 2 in osteoblasts</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kassem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Henning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">H</forename><surname>Lerner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">290</biblScope>
			<biblScope unit="issue">33</biblScope>
			<biblScope unit="page" from="20147" to="20158" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption</title>
		<author>
			<persName><forename type="first">E</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bachrach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shapira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nussbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immuno</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="8296" to="8300" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss</title>
		<author>
			<persName><forename type="first">G</forename><surname>Papadopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Weinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Massari</surname></persName>
		</author>
		<author>
			<persName><surname>Gibson Fc 3rd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Wetzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Genco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1148" to="1157" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Harber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Michalek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Katz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="24159" to="24169" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through toll-like receptor 2 with partial involvement of MyD88</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="823" to="831" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Stimulation by toll-like receptors inhibits osteoclast differentiation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1516" to="1523" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Dual modulation of osteoclast differentiation by lipopolysaccharide</title>
		<author>
			<persName><forename type="first">W</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Bar-Shavit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1211" to="1218" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Said-Al-Naief</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Michalek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Feng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="12512" to="12523" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">An endothelial receptor for oxidized low-density lipoprotein</title>
		<author>
			<persName><forename type="first">T</forename><surname>Sawamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Aoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Moriwaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Aiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Miwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Katsura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Masaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">386</biblScope>
			<biblScope unit="issue">6620</biblScope>
			<biblScope unit="page" from="73" to="77" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Goyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Mehta</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="419" to="429" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Cigarette smoke-exposed neutrophils die unconventionally but are rapidly phagocytosed by macrophages</title>
		<author>
			<persName><forename type="first">K</forename><surname>Guzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Skret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Smagur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bzowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gajkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Potempa</surname></persName>
		</author>
		<idno type="DOI">10.1038/cddis.2011.13</idno>
		<ptr target="https://doi.org/10.1038/cddis.2011.13" />
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/ apoptotic cells in endothelial cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Oka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sawamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kikuta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Itokawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Masaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="9535" to="9540" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">LOX-1 supports adhesion of gram-positive and gram-negative bacteria</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shimaoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Minami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hayashida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sawamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yonehara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="5108" to="5114" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The discovery of LOX-1, its ligands and clinical significance</title>
		<author>
			<persName><forename type="first">R</forename><surname>Yoshimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kakino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iwamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sawamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Drugs Ther</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="379" to="391" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kosaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoneyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Igarashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="636" to="643" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Lectin-like oxidized lowdensity lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice</title>
		<author>
			<persName><forename type="first">R</forename><surname>Takanabe-Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sowa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Horie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Satoh-Asahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shimatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sawamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hasegawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">398</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="576" to="580" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nakayachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hayashida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kakino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okayasu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ogasawara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kaneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sawamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hakeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="170" to="182" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey</title>
		<author>
			<persName><forename type="first">F</forename><surname>D'aiuto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sabbah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Netuveli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Donos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Deanfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tsakos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3989" to="3994" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Involvement of toll-like receptor 2 and 4 in association between dyslipidemia and osteoclast differentiation in apolipoprotein E deficient rat periodontium</title>
		<author>
			<persName><forename type="first">T T</forename><surname>Ekuni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Azuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Irie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kasuyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lipids Health Dis</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Metabolic diseases and their possible link to risk indicators of periodontitis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Noack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Roscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kopprasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>LÃ¼ck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hanefeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Periodontol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="898" to="903" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. Gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Koizumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kurita-Ochiai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Oguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2958" to="2965" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile</title>
		<author>
			<persName><forename type="first">T</forename><surname>Maekawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tabeta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Aoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Miyashita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Miyauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Miyazawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nakajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamazaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e20240</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Gudino</surname></persName>
		</author>
		<author>
			<persName><surname>Gibson Fc 3rd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Genco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Oral Microbiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="305" to="316" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Velsko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Chukkapalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bhattacharyya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Gangula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kesavalu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e97811</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Porphyromonas gingivalis accelerates atherosclerosis in C57BL/6 mice fed a high-fat diet</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fukasawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kurita-Ochiai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hashizume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Akimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunopharmacol Immunotoxicol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="470" to="476" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Unresponsiveness of MyD88-deficient mice to endotoxin</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kawai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Adachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ogawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="115" to="122" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling</title>
		<author>
			<persName><forename type="first">C</forename><surname>MaziÃ¨re</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Louvet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gomila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kamel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Massy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>MaziÃ¨re</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">221</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="572" to="578" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Immunobiotic lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the toll-like receptor signaling pathway</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shimazu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Villena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fujie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hosoya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimosato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Aso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Makino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ikegami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kitazawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="276" to="288" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Vascular calcification and osteoporosis: inflammatory responses to oxidized lipid</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Demer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="737" to="741" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Plasma lipids and osteoporosis in postmenopausal women</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sugimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sowa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chihara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr J</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="211" to="217" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Atherogenic high-fat diet reduces bone mineralization in mice</title>
		<author>
			<persName><forename type="first">F</forename><surname>Parhami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tintut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Beamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gharavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Demer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="182" to="188" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Role of lipids in osteoporosis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Parhami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Garfinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Demer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2346" to="2348" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kurokawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2381" to="2391" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion</title>
		<author>
			<persName><forename type="first">M</forename><surname>Okayasu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakayachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hayashida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kaneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Masuhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hakeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="19229" to="19241" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Lactobacillus acidophilus induces cytokine and chemokine production via NF-ÎºB and p38 mitogen-activated protein kinase signaling pathways in intestinal epithelial cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>LÃ¼</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Man</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Vaccine Immunol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="603" to="608" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients</title>
		<author>
			<persName><forename type="first">F</forename><surname>Parhami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Morrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Balucan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="680" to="687" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Stimulation of bone formation in vitro and in rodents by statins</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mundy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Garrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rossini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Boyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gutierrez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="issue">5446</biblScope>
			<biblScope unit="page" from="1946" to="1949" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebocontrolled trials</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Johnston</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Bjarnason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lindsay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Mitlak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Huster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Harper</surname></persName>
		</author>
		<author>
			<persName><surname>Heath H 3rd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gennari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Arnaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Delmas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="3444" to="3450" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Statins: lower lipids and better bones</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rogers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="21" to="23" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Statins: not just for cholesterol?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Toledano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Partridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="255" to="256" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Cholesterol drugs show promise as bone builders</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ferber</surname></persName>
		</author>
		<author>
			<persName><surname>Osteoporosis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">5475</biblScope>
			<biblScope unit="page" from="2297" to="2298" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Bisphosphonates and atherosclerosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ylitalo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gen Pharmacol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="287" to="296" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">American Heart Association rheumatic fever, endocarditis, and Kawasaki disease Committee of the Council on cardiovascular disease in the young, council on epidemiology and prevention, council on peripheral vascular disease, and council on clinical cardiology: periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Lockhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Bolger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Papapanou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Osinbowale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trevisan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Levison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Taubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Newburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Gornik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Gewitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Smith</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Baddour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="2520" to="2544" />
			<date type="published" when="2012">2012</date>
			<publisher>American Heart Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
